# FDA 483 - Patrick Clarke, M.D. - May 01, 2021

Source: https://www.globalkeysolutions.net/records/483/patrick-clarke-md/ee6f64c3-56a0-4517-a7f6-59b542b604af

> FDA 483 for Patrick Clarke, M.D. on May 01, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Patrick Clarke, M.D.
- Inspection Date: 2021-05-01
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Patrick Clarke, M.D. in Los Angeles, CA, was inspected from April 26 to May 1, 2021, as a clinical investigator. The inspection revealed significant deficiencies in conducting a clinical study, including failures to report adverse events and numerous protocol deviations. These issues indicate a lack of adherence to the investigational plan and signed statement of investigator.

## Related Officers

- [Stuart W. Russell](https://www.globalkeysolutions.net/people/stuart-w-russell/59719ee0-e7b3-4e10-8d87-7c79eb2c2192)

Company: https://www.globalkeysolutions.net/companies/patrick-clarke-md/e23d760e-96fa-4dc5-a3e2-18247d22519c

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6